Topics
Glioblastoma | Treatment | Pharmacotherapy | Antidiabetic drugs
Home > Publications > Topics > Glioblastoma > Treatment > Pharmacotherapy > Antidiabetic drugs
Shah S, Mansour HM, Aguilar TM, Lucke-Wold B.
Advances
in Anti-Cancer Drug Development: Metformin as Anti-Angiogenic
Supplemental Treatment for Glioblastoma.
Int
J Mol Sci. 2024 May 23;25(11):5694. doi:
10.3390/ijms25115694. PMID:
38891882.
ˍ
Dixon
S, O'connor AT, Brooks-Noreiga C, Clark MA, Levy A, Castejon AM.
Role
of renin angiotensin system inhibitors and metformin in
Glioblastoma Therapy: a review.
Cancer
Chemother Pharmacol.
2024 Jun 25. doi:
10.1007/s00280-024-04686-0. PMID:
38914751˰
ˍ
Begagić E, Džidić-Krivić A, Bečulić H,
Pugonja R, Ljevaković A, Bašić B, Nuhović A,
Milanović E, Hadžić S, Bećirović E, Buljubašić
L, Bećirović M, Pojskić M.
Glucose
and antidiabetic therapy in temozolomide resistance in
glioblastoma.
World
J Clin Oncol. 2025 Aug 24;16(8):108112. doi:
10.5306/wjco.v16.i8.108112. PMID:
40901320. ˍ
Maio V, Shah R, Lin M, J Moeller P, Alnahhas I, Hass R, Shi W,
Keith SW.
Metformin exposure after
glioblastoma diagnosis and mortality: A large population-based
study.
Neurooncol
Adv. 2026 Feb 16;8(1):vdag041. doi:
10.1093/noajnl/vdag041. PMID:
41788737. ˍ
Gonzales-Portillo D, Vashi B, Bains Williams K, Cervantes J.
Metformin Renders Survival Advantage
to Patients with Glioblastoma Multiforme.
Neurol
Int. 2026 Feb 24;18(3):40. doi:
10.3390/neurolint18030040. PMID:
41893042. ˍ